OTCMKTS:HBPCF

Helix BioPharma News Headlines

$0.69
0.00 (0.00 %)
(As of 05/10/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.69
$0.69
50-Day Range
$0.64
$0.73
52-Week Range
$0.22
$1.01
Volume20 shs
Average Volume1,665 shs
Market Capitalization$96.94 million
P/E RatioN/A
Dividend YieldN/A
Beta0.04

Headlines

Helix BioPharma (OTCMKTS HBPCF) News Headlines Today

SourceHeadline
Helix BioPharma Corp. (OTCMKTS:HBPCF) Sees Large Decline in Short InterestHelix BioPharma Corp. (OTCMKTS:HBPCF) Sees Large Decline in Short Interest
americanbankingnews.com - April 29 at 3:14 PM
Helix BioPharma Corp. Extends Period to Exercise WarrantsHelix BioPharma Corp. Extends Period to Exercise Warrants
finance.yahoo.com - April 9 at 6:50 PM
HBP.TO: LDOS006 New Sites OpenHBP.TO: LDOS006 New Sites Open
finance.yahoo.com - April 5 at 1:10 PM
NA Proactive news snapshot: American Battery Metals, Victory Square Technologies, Gevo, Metalla Royalty & Streaming UPDATENA Proactive news snapshot: American Battery Metals, Victory Square Technologies, Gevo, Metalla Royalty & Streaming UPDATE
proactiveinvestors.com - March 17 at 6:41 PM
NA Proactive news snapshot: Renforth Resources, Psyched Wellness, Ascendant Resources, KULR TechnologyNA Proactive news snapshot: Renforth Resources, Psyched Wellness, Ascendant Resources, KULR Technology
proactiveinvestors.com - March 17 at 1:40 PM
NA Proactive news snapshot: Vuzix Corporation, VR Resources, Todos Medical, Marvel Discovery UPDATENA Proactive news snapshot: Vuzix Corporation, VR Resources, Todos Medical, Marvel Discovery UPDATE
proactiveinvestors.com - March 17 at 1:40 PM
Helix BioPharma Corp. Appoints Dr. Frank Gary Renshaw To Scientific Advisory BoardHelix BioPharma Corp. Appoints Dr. Frank Gary Renshaw To Scientific Advisory Board
finance.yahoo.com - February 16 at 8:33 AM
Helix Biopharma Corp. Responds to Market ActivityHelix Biopharma Corp. Responds to Market Activity
finance.yahoo.com - January 13 at 4:38 PM
NA Proactive news snapshot: FansUnite Entertainment, First Cobalt, Newrange Gold, Innocan Pharma, Great Panther Mining UPDATE ...NA Proactive news snapshot: FansUnite Entertainment, First Cobalt, Newrange Gold, Innocan Pharma, Great Panther Mining UPDATE ...
proactiveinvestors.com - December 16 at 9:28 PM
HBP.TO: Polish Subsidiary Definitive SaleHBP.TO: Polish Subsidiary Definitive Sale
finance.yahoo.com - November 30 at 12:04 PM
Helix BioPharma and Moffitt Cancer center extends immunotherapy collaborationHelix BioPharma and Moffitt Cancer center extends immunotherapy collaboration
seekingalpha.com - August 12 at 1:21 PM
Helix BioPharma Corp. and Moffitt Cancer Center Extend Immunotherapy CollaborationHelix BioPharma Corp. and Moffitt Cancer Center Extend Immunotherapy Collaboration
finance.yahoo.com - August 12 at 8:13 AM
HBP.TO: Helix BioPharma Announces 3Q:20 ResultsHBP.TO: Helix BioPharma Announces 3Q:20 Results
finance.yahoo.com - August 10 at 11:14 AM
49 Public Companies to Present at the SNN Network Virtual Conference on August 3-6, 202049 Public Companies to Present at the SNN Network Virtual Conference on August 3-6, 2020
finance.yahoo.com - August 3 at 8:11 AM
Helix BioPharma Corp. to Present at the SNN Network Virtual ConferenceHelix BioPharma Corp. to Present at the SNN Network Virtual Conference
finance.yahoo.com - July 31 at 6:35 PM
Helix BioPharma Corp. to Present at Alpha Bronze Virtual Town HallHelix BioPharma Corp. to Present at Alpha Bronze Virtual Town Hall
finance.yahoo.com - July 27 at 9:05 AM
HBP.TO: Helix BioPharma Pitches at Proactive’s One2One Virtual ForumHBP.TO: Helix BioPharma Pitches at Proactive’s One2One Virtual Forum
finance.yahoo.com - June 24 at 3:06 PM
Have Insiders Been Buying Helix BioPharma Corp. (TSE:HBP) Shares This Year?Have Insiders Been Buying Helix BioPharma Corp. (TSE:HBP) Shares This Year?
finance.yahoo.com - May 20 at 9:52 AM
Helix BioPharma announces data from L-DOS47 dose escalation study of non-small cell lung cancer patientsHelix BioPharma announces data from L-DOS47 dose escalation study of non-small cell lung cancer patients
www.proactiveinvestors.com - May 14 at 9:09 AM
HBP.TO: Pancreatic Trial EnrollingHBP.TO: Pancreatic Trial Enrolling
finance.yahoo.com - April 6 at 3:15 PM
Helix BioPharma maintaining business continuity amid coronavirus pandemicHelix BioPharma maintaining business continuity amid coronavirus pandemic
www.proactiveinvestors.com - April 2 at 3:43 PM
Noble reiterates Outperform rating on Helix BioPharma following in-line 2Q resultsNoble reiterates Outperform rating on Helix BioPharma following in-line 2Q results
www.proactiveinvestors.com - March 18 at 12:23 PM
HBP.TO: A New Approach to Enhance Standard of CareHBP.TO: A New Approach to Enhance Standard of Care
finance.yahoo.com - January 9 at 4:26 PM
This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.